Evidence map›Paper›PMID 35497377›Full record

ArticleToxicology communications2022

Severe colchicine poisoning treated successfully with kidney replacement therapy and plasmapheresis: a case report.

D H Schaffer, D L Overbeek, T B Erickson, E W Boyer, C Goldfine, S A Muhsin, P R Chai

Abstract read
In one paragraph

Article in Toxicology communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

D H SchafferDepartment of Emergency Medicine, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0002-1597-0726
D L OverbeekDepartment of Emergency Medicine, University of Rochester Medical Center, Rochester, NY, USA.
T B EricksonDepartment of Emergency Medicine, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0002-1809-4805
E W BoyerDepartment of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
C GoldfineDepartment of Emergency Medicine, Brigham and Women's Hospital, Boston, MA, USA.
S A MuhsinRenal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
P R ChaiDepartment of Emergency Medicine, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0003-0955-4117

Funding

MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence among HIV+ Prescription Opioid UsersR01DA047236 · NIDA · OHIO STATE UNIVERSITY · PI BOYER, EDWARD W, CARRICO, ADAM WAYNE · 2019 to 2022
$3.0M
A novel robotic wastewater analysis system to quantify opioid exposure and treatment in residential communitiesR44DA051106 · NIDA · BIOBOT ANALYTICS, INC. · PI CHAI, PETER R, MATUS GARCIA, MARIANA G · 2020 to 2022
$1.5M
Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance UsersK23DA044874 · NIDA · BRIGHAM AND WOMEN'S HOSPITAL · PI CHAI, PETER R · 2018 to 2022
$1.0M
NIDA NIH HHS K23 DA044874NIDA NIH HHS R01 DA047236NIDA NIH HHS R44 DA051106
6 · The paper itself

Abstract

Colchicine is commonly prescribed for treatment of inflammatory conditions but has a narrow therapeutic window and dangerous toxicity profile. Here we describe a case of survival after massive unintentional colchicine overdose treated with plasmapheresis and renal replacement therapy. A 37 year old male with history of pericarditis presented to the Emergency Department with a chief complaint of nausea, vomiting, and diarrhea after unintentionally ingesting 36 mg of colchicine 17 h prior to arrival. An initial colchicine concentration resulted at 5.1 ng/mL (30 h post-ingestion) and peaked at 12 ng/mL (40 h post-ingestion). He was treated with continuous kidney replacement therapy (CKRT) beginning on his first day of hospitalization and with plasmapheresis on hospital days two through four. The patient's course was complicated by multiorgan failure including coagulopathy, respiratory failure, neuropathy, renal failure, pancytopenia, and heart failure. He was discharged to inpatient rehabilitation on hospital day 24. On clinical follow up four months after discharge the patient was found to have no significant persistent morbidity related to colchicine overdose.

Indexed as

case reportColchicineoverdoseplasmapharesis

Identifiers

PMID35497377
PMCPMC9049641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.